Civica Interested In Retired Or Withdrawn ANDAs

Seeks Talks With Manufacturers Over 250 ANDAs For Essential Medicines

As a part of its strategy to develop its own ANDAs for essential medications, Civica has expressed interest in taking over existing ANDAs that are being retired or withdrawn by other generics manufacturers.

Files
Civica stand ready to takeover ANDAs that may be retired or withdrawn • Source: Shutterstock

Hospital purchasing group Civica Rx says it is interested in talking to generics manufacturers which are considering retiring or withdrawing their abbreviated new drug applications for essential medicines that are at risk of being in short supply.

The announcement by the group with membership representing over 1,200 US hospitals came shortly after the US Food and Drug...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains

Test

Wagner Adds Germany To Role As Stada Simplifies Structure

Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

Type:DisclosureDevelopments | Publication:GB | Section:Business | Paywall:Free — Article containing all Composer content for testing (Do not update)

 
• By 

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.

More from Business

uygukgigo

 
• By 

Test

Podcast test

 
• By